These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 21738007)
21. HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Granato M; Lacconi V; Peddis M; Lotti LV; Di Renzo L; Gonnella R; Santarelli R; Trivedi P; Frati L; D'Orazi G; Faggioni A; Cirone M Cell Death Dis; 2013 Jul; 4(7):e730. PubMed ID: 23868063 [TBL] [Abstract][Full Text] [Related]
22. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748 [TBL] [Abstract][Full Text] [Related]
23. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues. O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154 [TBL] [Abstract][Full Text] [Related]
24. p53-Dependent and -independent functions of the Arf tumor suppressor. Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746 [TBL] [Abstract][Full Text] [Related]
25. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362 [TBL] [Abstract][Full Text] [Related]
26. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Leu JI; Pimkina J; Pandey P; Murphy ME; George DL Mol Cancer Res; 2011 Jul; 9(7):936-47. PubMed ID: 21636681 [TBL] [Abstract][Full Text] [Related]
27. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF. Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711 [TBL] [Abstract][Full Text] [Related]
28. Autophagy by ARF: a short story. Sherr CJ Mol Cell; 2006 May; 22(4):436-7. PubMed ID: 16713573 [TBL] [Abstract][Full Text] [Related]
29. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis. Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716 [TBL] [Abstract][Full Text] [Related]
31. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322 [TBL] [Abstract][Full Text] [Related]
32. p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins. Müer A; Overkamp T; Gillissen B; Richter A; Pretzsch T; Milojkovic A; Dörken B; Daniel PT; Hemmati P J Biol Chem; 2012 May; 287(21):17343-17352. PubMed ID: 22354970 [TBL] [Abstract][Full Text] [Related]
34. Emerging roles of mitochondrial p53 and ARF. Itahana Y; Itahana K Curr Drug Targets; 2012 Dec; 13(13):1633-40. PubMed ID: 22998186 [TBL] [Abstract][Full Text] [Related]
35. Defining the molecular basis of Arf and Hdm2 interactions. Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560 [TBL] [Abstract][Full Text] [Related]
36. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway. Kamrul HM; Wadhwa R; Kaul SC Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193 [TBL] [Abstract][Full Text] [Related]
37. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression. Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177 [TBL] [Abstract][Full Text] [Related]
38. The ARF tumor suppressor can promote the progression of some tumors. Humbey O; Pimkina J; Zilfou JT; Jarnik M; Dominguez-Brauer C; Burgess DJ; Eischen CM; Murphy ME Cancer Res; 2008 Dec; 68(23):9608-13. PubMed ID: 19047137 [TBL] [Abstract][Full Text] [Related]
39. Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Hemmati PG; Güner D; Gillissen B; Wendt J; von Haefen C; Chinnadurai G; Dörken B; Daniel PT Oncogene; 2006 Oct; 25(50):6582-94. PubMed ID: 16847458 [TBL] [Abstract][Full Text] [Related]
40. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]